Top 50 Health Care VC Funds & Investors in Hong Kong (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Gobi Partners
VC Fund
|
5 | China, Malaysia, Hong Kong | Series A, Seed, Series B | E-Commerce, Financial Services, Internet | $800k–$37M |
|
Alibaba Entrepreneurs Fund
VC Fund
|
4 | Hong Kong, Taiwan, United States | Series A, Seed, Series B | Software, E-Commerce, Artificial Intelligence | $510k–$150M |
|
Apricot Capital
VC Fund
|
3 | China, United States, Hong Kong | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $3M–$58M |
|
5Y Capital
VC Fund
|
3 | China, United States, India | Series A, Series B, Series C | Artificial Intelligence, Biotechnology, Software | $5M–$400M |
|
Groove Capital
VC Fund
|
2 | United States, Hong Kong, Mauritius | Seed, Pre-Seed, Series A | Software, Health Care, Information Technology | $120k–$3.3M |
|
Seveno Capital
VC Fund
|
2 | Japan, Hong Kong, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Sensor, Travel, Wearables | |
|
HSG
VC Fund
|
2 | China, United States, Australia | Series B, Series A, Seed | Artificial Intelligence, Biotechnology, Software | $2M–$293M |
|
Simmons Foods
VC Fund
|
2 | Hong Kong | Seed | Medical, Agriculture, Biotechnology | |
|
Novel Tycoon
VC Fund
|
2 | Hong Kong | Seed | Nutrition, Organic Food | $1.3M–$1.3M |
|
FHB Ventures
VC Fund
|
2 | Hong Kong, United States | Seed, Series A, Series B | Medical, Agriculture, Biotechnology | |
|
Qiming Venture Partners
VC Fund
|
2 | China, United States, Hong Kong | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5M–$142M |
|
Arkansas Development Finance Authority
VC Fund
|
2 | United States, Hong Kong | Seed, Pre-Seed | Medical, Biotechnology, Fashion | |
|
Picus Capital
VC Fund
|
2 | Germany, United States, United Kingdom | Seed, Series A, Pre-Seed | Financial Services, Software, FinTech | $549k–$33M |
|
Med-Fine Capital
VC Fund
|
2 | China, Hong Kong, United States | Series A, Seed, Series B | Medical, Health Care, Biotechnology | $2.8M–$60M |
|
Hony Capital
VC Fund
|
2 | China, United States, Hong Kong | Series A, Series B | E-Commerce, Biotechnology, Food and Beverage | $3.8M–$390M |
|
Cowin Venture
VC Fund
|
2 | China, United States, Hong Kong | Series A, Angel, Series B | Health Care, Medical, Biotechnology | $425k–$257M |
|
Vectr
VC Fund
|
2 | United States, Hong Kong, Singapore | Seed, Series A, Series B | FinTech, Financial Services, Artificial Intelligence | $547k–$70M |
|
BioVenture
VC Fund
|
2 | China, United States, Hong Kong | Series A, Series B, Seed | Health Care, Medical, Biotechnology | $1.9M–$73M |
|
Particle Accelerator Limited (ParticleX)
VC Fund
|
2 | Hong Kong, United States, Singapore | Seed, Pre-Seed, Series A | Artificial Intelligence, Information Technology, Software | $1M–$6.9M |
|
Whist Subholdings
VC Fund
|
2 | Hong Kong | Seed | Medical, Agriculture, Biotechnology | |
|
Chartwell Ventures
VC Fund
|
2 | Hong Kong | Seed | Nutrition, Organic Food | $1.3M–$1.3M |
|
FJ Labs
VC Fund
|
2 | United States, Brazil, United Kingdom | Seed, Series A, Series B | Software, E-Commerce, Financial Services | $1.4M–$65M |
|
Bold Capital Partners
VC Fund
|
2 | United States, Hong Kong, India | Series A, Series B, Seed | Health Care, Biotechnology, Software | $2M–$58M |
|
FEBE Ventures
VC Fund
|
2 | Singapore, Vietnam, Thailand | Seed, Series A, Pre-Seed | FinTech, Financial Services, Software | $780k–$30M |
|
PT Medion
VC Fund
|
2 | Hong Kong | Seed | Medical, Agriculture, Biotechnology | |
|
SOSV
VC Fund
|
2 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Emerging Technology Partners
VC Fund
|
1 | United States, China, Hong Kong | Series B, Series A | Biotechnology, Health Care, Medical | $3.4M–$9.9M |
|
ETP Ventures
VC Fund
|
1 | China, Hong Kong | Seed, Angel, Series A | Health Care, Biotechnology, Medical | |
|
StartUp Health
VC Fund
|
1 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Iflytek
VC Fund
|
1 | China, Hong Kong | Series A, Angel, Seed | Artificial Intelligence, Information Technology, Software | $142k–$99M |
|
Juvenescence
VC Fund
|
1 | United States, Hong Kong, Isle of Man | Series A, Debt Financing | Biotechnology, Pharmaceutical, Health Care | $3M–$19M |
|
WuXi AppTec
VC Fund
|
1 | United States, China, Israel | Series A, Series B, Series C | Biotechnology, Pharmaceutical, Health Care | $6M–$130M |
|
Maverick Ventures
VC Fund
|
1 | United States, Israel, India | Series A, Series C, Seed | Health Care, Medical, Biotechnology | |
|
Working Capital
VC Fund
|
1 | United States, United Kingdom, Spain | Seed, Series A, Series B | Supply Chain Management, Machine Learning, Artificial Intelligence | |
|
Alon Capital Ltd
VC Fund
|
1 | Hong Kong | Series A | Biopharma, Life Science, Biotechnology | |
|
The International Medical
VC Fund
|
1 | Hong Kong | Seed | Medical, Hospitality, Biotechnology | |
|
Formic Ventures
VC Fund
|
1 | United States, United Kingdom, Hong Kong | Seed, Series A | Biotechnology, Health Care, Biopharma | $1.3M–$61M |
|
Longevity Vision Fund
VC Fund
|
1 | United States, Hong Kong, Isle of Man | Series B, Series C, Series A | Biotechnology, Health Care, Medical | $37M–$300M |
|
Proxima Ventures Ltd
VC Fund
|
1 | China, United States, Israel | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $213k–$150M |
|
Ping An
VC Fund
|
1 | China, United States, Japan | Series A, Series E | Health Care, FinTech, Finance | $1.4M–$300M |
|
LongeVC
VC Fund
|
1 | United States, United Kingdom, Canada | Seed, Series A | Health Care, Biotechnology, Therapeutics | $1.5M–$94M |
|
DNA Capital
VC Fund
|
1 | United States, Brazil, China | Seed, Series A, Series B | Health Care, Medical, Hospital | $250k–$30M |
|
WI Harper Group
VC Fund
|
1 | United States, Taiwan, China | Series A, Seed, Series B | Software, Health Care, Biotechnology | $1.4M–$41M |
|
Huagai Capital
VC Fund
|
1 | China, United States, Germany | Series A, Series B, Angel | Health Care, Biotechnology, Medical | $425k–$90M |
|
Capital Union Investments
VC Fund
|
1 | Hong Kong, United States | Seed, Series A | SaaS, Genetics, Software | $2M–$10M |
|
Hillhouse Investment
VC Fund
|
1 | China, United States, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Software | $2.9M–$230M |
|
Angelsdeck Global Ventures
VC Fund
|
1 | United States, Russian Federation, Brazil | Seed, Pre-Seed, Angel | Artificial Intelligence, Software, Education | $80k–$6M |
|
A.Partners
VC Fund
|
1 | United States, Russian Federation, Peru | Seed, Pre-Seed, Series A | Education, EdTech, Software | $700k–$6.4M |
|
Artesian VC
VC Fund
|
1 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
Coent Venture Partners
VC Fund
|
1 | Taiwan, China, Hong Kong | Seed, Series A | Apps, SaaS, Travel | $275k–$800k |
| Access all 215 VC funds in Hong Kong Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.
Show more...Investment focus
- Industry: E-Commerce, Financial Services, Internet
- Stage:Series A, Seed, Series B
- Geography: China, Malaysia, Hong Kong
Investor stats
- Total investments: 237
- Round size: Seed $800k–$7M; Series A $1.5M–$20M; Series B $5.5M–$37M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $1.3B in 2023
Portfolio highlights
- Carsome — Carsome is an online used car platform that provides efficient car selling services to individuals and entities. Through its online bidding portal, customers are able to sell their vehicles directly to dealers. Carsome facilitates the entire car selling process from inspection to valuation, bidding, and payment as well as logistics needs, allowingthe customers to sell their cars.It was founded in 2015 and headquartered in Malaysia, the company has expanded to Indonesia, Thailand, and Singapore.
- Deliveree Logistics — Feb 1, 2022 - Welcome to the revolution. With the largest truck fleet in Southeast Asia, we provide businesses with first, mid, and last mile transportation.
- PanopticAI — PanopticAI is a health system that uses artificial intelligence and signal processing to comprehend the human body and improve health.
The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Hong Kong, Taiwan, United States
Investor stats
- Total investments: 68
- Round size: Seed $510k–$7M; Series A $2M–$68M; Series B $7M–$150M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $130M in 2015
Portfolio highlights
- PanopticAI — PanopticAI is a health system that uses artificial intelligence and signal processing to comprehend the human body and improve health.
- Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
- Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 44
- Round size: Seed $10M–$41M; Series A $3M–$54M; Series B $14M–$58M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Vibrant — Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects tocontinuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization.It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
- Zhonghe Gene — Zhonghe Gene is a gene technology developer, primarily involved in the research and development of DNA biosynthesis technology.
- Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
5Y Capital is a firm engaged in providing early-stage venture investments. It was formerly known as Morningside Venture Capital. The investment firm manages USD 5bn in dual-currency funds in USD and RMB, backed by world-renowned sovereign wealth funds, family offices, fund of funds, university endowments, pensions, and foundations. It is aninvestment firm of Morningside Group.It was headquartered in Xuhui, Shanghai, China in 2008 by Ken Shi and Richard Liu.
Show more...Investment focus
- Industry: Artificial Intelligence, Biotechnology, Software
- Stage:Series A, Series B, Series C
- Geography: China, United States, India
Investor stats
- Total investments: 235
- Round size: Series A $5M–$102M; Series B $10M–$227M; Series C $30M–$400M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- X-EPIC — X-EPIC is a Nanjing city-based startup aimed at building up China’s own EDA (Electronic Design Automation) industrial software technology.
- Zhongke Guosheng — Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials.
- ReviR Therapeutics — ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Groove Capital is a new investment firm targeting early-stage companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Hong Kong, Mauritius
Investor stats
- Total investments: 131
- Round size: Seed $405k–$3.3M; Pre-Seed $120k–$2M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- BetterYou — Transform your wellness journey with BetterYou, the personalized productivity coach that helps you achieve your goals efficiently and effectively.
- Carbon Origins — Carbon Origins is a robotics company on a mission to Make Robots Commonplace.
- Character — The next-gen home improvement destination.
Seveno Capital is a venture capital fund backing early and growth-stage ventures with the holistic potential to extend human healthspan. Seveno Capital specialises in providing strategic capital and expert guidance to visionary entrepreneurs around the world.Seveno Capital is dedicated to seeding and nurturing the growth of businesses that aremaking a positive impact, rooted in a deep understanding of the interplay between fitness, holistic wellness and longevity solutions in extending the human healthspan.Seveno Capital is committed to fostering innovation and scalability by providing strategic capital and expertise to accelerate the growth of purpose-driven ventures whilst also ensuring that financial returns are intrinsically linked to positive social outcomes. Seveno Capital is backed by Allen Law, an investor with 20 years of global leadership in hospitality, wellness, fitness and longevity. Allen Law is also Founder at Park Hotel Group, Co-Founder at MOVE [REPEAT] and is Chairman at REVL Training.
Show more...Investment focus
- Industry: Sensor, Travel, Wearables
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Japan, Hong Kong, United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- A Cabin Company — A cabin company is a company that creates and operates small, attractively built cottages located in rural or semi-rural locations. These cabins are designed to promote human health and wellness by providing access to healing natural environments.
- PointFit Technology — PointFit Technology develops non-invasive wearable devices that monitor health through sweat biomarkers. They provide real-time, continuous health insights, making them useful for both wellness and potential medical applications. Their aim is to offer a seamless and convenient way to track health metrics without the need for invasive procedures.They are positioned within the sporting goods industry that focuses on the future of sports wearables.
- Longevity Technology — Longevity Technology is a daily news and insights on research, investments and technologies that extend life.
HSG is a leading venture capital and private equity firm investing globally in the technology, healthcare, and consumer sectors.
Show more...Investment focus
- Industry: Artificial Intelligence, Biotechnology, Software
- Stage:Series B, Series A, Seed
- Geography: China, United States, Australia
Investor stats
- Total investments: 197
- Round size: Seed $2M–$42M; Series A $14M–$143M; Series B $12M–$293M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- SceneRay — Sceneray Co. Ltd, located at Singapore Industrial Park in Suzhou China, is a medical device company dedicated to the design, development, and distribution of neuromodulation devices. The core team of Sceneray is made up by experts with deep China and overseas experiences in neuromodulation device development, manufacturing, and marketing. Scenerayholds many patents and keeps on exploring the frontiers in neuromodulation. Being an international high-tech medical and competitive company, Sceneray is dedicated to providing patients with high-quality and efficacious treatments.
- DentaLink China — Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.
- Suisheng Technology — Suisheng Technology is an innovative company specializing in AI-driven memory services, dedicated to developing intelligent solutions that help individuals and businesses capture, organize, and retrieve important information with greater efficiency and precision.
Simmons Foods is a leading supplier of poultry, pet and ingredient products based in Siloam Springs, Arkansas.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Novel Tycoon
Show more...Investment focus
- Industry: Nutrition, Organic Food
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Round size: Seed $1.3M–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Future salad — Allklear is a Hong Kong food tech startup combining nature and technology.
FHB Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Hong Kong, United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- EarthOptics — EarthOptics is building the cloud-based machine learning platform for soil and ground management.
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 740
- Round size: Series A $5M–$64M; Series B $10M–$100M; Series C $15M–$142M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $887M in 2023
Portfolio highlights
- Plum — Plum is an e-commerce platform for second-hand fashion products. It works as a one-stop consignment service platform that provides filming, sales, customer service, sale, and a full set of consignment services. Plum was founded on 2015 and is headquartered in Beijing, China.
- Bytelumio — Bytelumio creates advanced all-optical networks that deliver high-speed connections of 800G and 1.6T for data centers.
- Guangjing Energy — Guangjing Energy is a perovskite solar cell module developer, dedicated to the R&D of long-life large-area perovskite solar cell modules.
Welcome to Arkansas Development Finance Authority (ADFA), your source for safe, decent, affordable housing in Arkansas. Contact us at (501) 682-5900 to secure your dream home today!
Show more...Investment focus
- Industry: Medical, Biotechnology, Fashion
- Stage:Seed, Pre-Seed
- Geography: United States, Hong Kong
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Ascendant Dx — Choose An Online Slot Game
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
- BlueOak Resources — BlueOak: Sourcing Metals Sustainably™ from End-of-Life Electronics.BlueOak believes in the philosophy of resource and capital efficiency. They are building distributed mini-refineries that use proven, capital-efficient refining processes towards extracting precious metals and rare earth elements from e-waste. Their vision is to revolutionize howwe treat end of life electronics: converting the e-waste of today into a sustainable source of critical metals and rare earths for the technologies of tomorrow.
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more...Investment focus
- Industry: Financial Services, Software, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 341
- Round size: Seed $1.5M–$11M; Pre-Seed $549k–$4.5M; Series A $3.7M–$33M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $140M in 2024
Portfolio highlights
- Solarize — Solarize provides SaaS for energy production, distribution and billing for commercial microgrids.
- D2X Group — Trade digital asset options and futures on the EU-regulated market infrastructure for institutions.
- Lightbase — Plan, align, and ship complex projects faster. Lightbase maps your architecture across services and hands agents the full context to make safe, coordinated changes.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 78
- Round size: Seed $8M–$60M; Series A $2.8M–$40M; Series B $11M–$60M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $69M in 2019
Portfolio highlights
- Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
- Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
- BV Laser — BV Laser is a manufacturer of medical beauty equipment.
Founded in 2003, Hony Capital is a pioneer in China’s home grown private equity industry. Sponsored by Legend Holdings, a leading Chinese conglomerate, Hony has blazed the trail in formulating private equity investment strategies suitable for Chinese conditions by combining a deep understanding of local environment and people with global resourcesand international best practices. Today, with over USD 6.8 billion in assets under management across 7 funds and investments in over 60 companies, Hony is a leading China-focused private equity firm.Adhering to the “value creation” investment philosophy, Hony partners with managers and entrepreneurs to build their businesses into sustainable leaders in respective industries. Hony focuses on sectors where it has developed expertise: pharmaceuticals and healthcare, consumer & retail, media & entertainment, financial services, construction materials, machinery, and alternative energy & resources
Show more...Investment focus
- Industry: E-Commerce, Biotechnology, Food and Beverage
- Stage:Series A, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 68
- Round size: Series A $6.4M–$390M; Series B $3.8M–$76M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Alioth — Elios focuses on the development and application of technical products for pharmaceutical process technology.
- LaNova Medicines — LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
- Zhongguancun Shuimu Medical Technology — Shuimu Medical is a third-party professional medical device inspection and testing institution.
Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Angel, Series B
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 97
- Round size: Angel $425k–$1.4M; Series A $1.4M–$28M; Series B $2.8M–$257M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Furong Biotech — Furong Bio is a developer of innovative tumor immunology drugs.
- Amador Bioscience — At Amador we provide global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies.
- BioTroy Therapeutics — BioTroy Therapeutics is engaged in tumor immunity and is used for multi-omics tumor analysis, receptor-ligand discovery, research on target signal transduction pathways, antibody discovery and engineering, drug efficacy and large animal translational medicine, biomarkers, and precision medicine.
Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.
Show more...Investment focus
- Industry: FinTech, Financial Services, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Hong Kong, Singapore
Investor stats
- Total investments: 74
- Round size: Seed $547k–$5.3M; Series A $1M–$37M; Series B $12M–$70M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
- Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
- MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, United States, Hong Kong
Investor stats
- Total investments: 165
- Round size: Seed $7.1M–$20M; Series A $1.9M–$43M; Series B $3M–$73M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Jiamuyao Medical — Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions.
- Xingyuanzhi Robotics — Xingyuanzhi Robotics strives to develop multimodal spatial intelligence systems and a universal embodied brain capable of comprehending and interacting with the physical world.
- MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Particle Accelerator Limited (ParticleX) was founded in late 2017 by Shine Works. ParticleX is a tech-based startup investor and accelerator based in Hong Kong. ParticleX combines network, capital and research resources, accelerating the pace of innovative technology and helping the early-stage startups to win cross-border opportunities acrossAsia.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Hong Kong, United States, Singapore
Investor stats
- Total investments: 22
- Round size: Seed $1.2M–$5.5M; Series A $1M–$6.9M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Finquest — Tap into the largest private company database in the world to change the way you find and connect with M&A targets using Data, AI, & People.
- MediConCen — MediConCen is a medical network that mobilize medical experts all over the world to serve the insured population without middleman. They revolutionize the current medical network with Blockchain technology. MediConCen liberalizes the existing heavily walled medical network with the use of Blockchain technology, allowing individual clinics to rejointhe insurance market with a one-stop solution. The next generation medical ecosystem starts right here.MediConCen aims to integrate all clinics, insured employees and business entities into a unified Blockchain ecosystem, making business truly efficient, transparent and trustworthy.
- Crown Digital — Crown Digital harnesses the future-ready power of robotics and Artificial Intelligence to open doors with cutting-edge solutions for the not-so-distant future.
Whist Subholdings is a venture capital investment firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Chartwell Ventures is an investment firm.
Show more...Investment focus
- Industry: Nutrition, Organic Food
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Round size: Seed $1.3M–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Future salad — Allklear is a Hong Kong food tech startup combining nature and technology.
FJ Labs is a stage-agnostic investment firm that focuses on marketplaces and consumer facing startups.
Show more...Investment focus
- Industry: Software, E-Commerce, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Brazil, United Kingdom
Investor stats
- Total investments: 897
- Round size: Seed $1.4M–$10M; Series A $4.4M–$30M; Series B $12M–$65M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $5.5M in 2016
Portfolio highlights
- Fresha — Find the best salons and spa in your area with Fresha salon booking software. Book now!
- Lastro — Lastro is an all-in-one real estate management platform with integrated payments that simplifies managing rental properties. It helps landlords streamline workflows by organizing lease contract information in a cloud-based system, automating rent charging processes, monitoring tenant obligations and generating customized reports.
- POC Pharma — POC Pharma is a SaaS company helping the stakeholders in the Pharmacy Channel to digitally manage their go to market strategy.
A collection of entrepreneurs, engineers, physicists, doctors, surfers, and musicians who are committed to helping entrepreneurs achieve their dreams of changing the world.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: United States, Hong Kong, India
Investor stats
- Total investments: 126
- Round size: Seed $2M–$15M; Series A $6M–$40M; Series B $15M–$58M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- KeyCare — KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care.
- Liquid AI — Liquid AI is an MIT spin-off with a presence in Boston, MA, and Palo Alto, CA. Our mission is to build state-of-the-art, general-purpose AI systems from first principles and deploy capable, efficient, highly aligned, and trustworthy AI for all.
- Gallant — Gallant Pet is a pet service company that develops a stem cell therapy intended for dog wounds.The company offers services that include retrieving valuable stem and regenerative cells, enabling pet owners to preserve their pet's young stem, and use them in treatment when necessary.Gallant Pet was established in 2018 by Aaron Hirschhorn andis headquartered in San Diego, California.
FEBE Ventures (“For Entrepreneurs, By Entrepreneurs”) is an early stage Venture Capital fund supporting outstanding entrepreneurs in Vietnam & Southeast Asia. The fund is managed by 4 entrepreneurs with +28 years of experience building and scaling companies in Vietnam & Southeast Asia, and investing in tech startups in Asia, Europe andSouth America. We apply a value-added approach, backing the best founders and offering our local business expertise, operational know-how, and global network.
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Singapore, Vietnam, Thailand
Investor stats
- Total investments: 51
- Round size: Seed $1.5M–$4.9M; Pre-Seed $780k–$2.4M; Series A $6M–$30M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $75M in 2023
Portfolio highlights
- HD — Guiding patients to the right next step and connecting them to real-world care with AI. Trusted by 500k+ patients and 3k+ providers.
- Prósperos — Founded in 2023 by Vinay Pai and Salvador Chavez, Prósperos is delivering an innovative financial platform that allows millions of Latinos to manage their finances while taking care of their family in the USA and Latin America.The Prósperos platform provides two bank accounts and two cards– one for the account holder in the USA and one for theirfamily in Mexico, and soon Central and South America. With Prósperos, customers can say goodbye to slow and costly money-transfer solutions, and their families no longer need to wait in line to pick up cash. Within seconds, funds are available to family members in Latin America.
- Nano Technologies — VUI provides Flexible Payroll (EWA) solutions, income statistics, and employee financial management education through a technology platform.
PT Medion is a venture capital investment firm.
Show more...Investment focus
- Industry: Medical, Agriculture, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providingsuperior returns to their investors.ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, China, Hong Kong
Investor stats
- Total investments: 11
- Round size: Series B $3.4M–$9.9M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Human Longevity — Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.
- CASI Pharmaceuticals — CASI is a NASDAQ-listed biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products.
- Heranova Lifesciences — Hekaiwei is a provider of innovative solutions for women's health.
ETP Ventures
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Angel, Series A
- Geography: China, Hong Kong
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- SEIMEI — SEIMEI is a nutrition and anti-aging biotechnology brand.
- Dima Biotech — DIMA uses HEK293 mammalian cell expression system to produce many druggable proteins especially membrane proteins. This will not only ensure the authentic
- Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 194
- Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
- Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Anhui USTC iFLYTEK Science and Technology Co., Ltd. (科大讯飞) is a software enterprise focused on the research of intelligent speech and language technologies, development of software and chip products, provision of speech information services, and integration of e-government systems.As a key supplier of intelligent speech technologies, USTCiFLYTEK holds long-term research experience in the field of intelligent speech technologies, and reputed achievements in a variety of technologies such as speech synthesis, speech recognition and spoken language evaluating.
Show more...Investment focus
- Industry: Artificial Intelligence, Information Technology, Software
- Stage:Series A, Angel, Seed
- Geography: China, Hong Kong
Investor stats
- Total investments: 82
- Round size: Seed $142k–$99M; Angel $425k–$21M; Series A $1.4M–$15M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Liangyi Wanxiang — Liangyi Wanxiang is focuses on complete machines, product R&D, and technological innovation in atomic quantum computing.
- Chengdu RainZhiLingdong Technology — Chengdu RainZhiLingdong Technology is a robotics company that offers an AI powered bionic plush pet toy.
- Anhui Xinglian Artificial Intelligence Technology — Anhui Xinglian Artificial Intelligence Technology develops artifical intelligence application software.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Debt Financing
- Geography: United States, Hong Kong, Isle of Man
Investor stats
- Total investments: 13
- Round size: Series A $3M–$19M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- LyGenesis — LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
- MDI Therapeutics — MDI Therapeutics is an operator of a discovery stage company focused on developing novel therapies for fibrotic diseases. The company have developed a proprietary discovery platform which has successfully identified novel small molecule and protein drug candidates, and have advanced these programs through key translational experiments usingclinical biomarkers.
- Souvien Therapeutics — Souvien Therapeutics is a biotechnology company focused on developing therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 45
- Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$40M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $250M in 2015
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Maverick Ventures is the venture arm of multi-billion dollar investment firm Maverick Capital. Combining the resources of a global firm with the benefits of an agile, focused team, Maverick Ventures supports entrepreneurs from seed through maturity. With over 30 years of early-stage investment experience, the Maverick Ventures team has funded morethan 100 companies in the healthcare, software and deep technology sectors. The highly-experienced team of operating executives and investors at Maverick Ventures generally lead rounds, take board seats and work with management to build successful enterprises.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series C, Seed
- Geography: United States, Israel, India
Investor stats
- Total investments: 171
- Lead/follow: no public data
Portfolio highlights
- Proximie — Proximie enables healthcare organizations, surgeons, and medical device companies to improve patient safety, scale training efforts, and accelerate device adoption, all while driving substantial savings in cost and time.
- HumanFirst — HumanFirst enables better integration and analysis of digital health technologies in clinical trials.
- Nourish — Achieve your desired health and wellness through personalized nutrition counseling. Nourish is the easiest way to find a registered dietitian and get it covered by your insurance. Find a dietitian today and start your telehealth appointments.
Working Capital process is supply chain intervention, philanthropic sidecar, and theory of change. They invests in scalable innovations to meet the growing corporate demand for more transparent and ethical supply chains addressing the urgent need to protect vulnerable workers and source responsibly.
Show more...Investment focus
- Industry: Supply Chain Management, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 22
- Lead/follow: no public data
Portfolio highlights
- Elm AI (Formerly Esger) — Esger's AI agents simplify ESG regulations compliance for companies within the supply chain
- minu — In minu, we are revolutionizing the financial health of Mexican employees, offering them access to their already worked salary when they need it, instead of having to wait for payroll. We work with HR areas of companies that offer the provision of minu to improve satisfaction, retention, and attraction of talent. minu is supported by FinTech'sleading institutional investors globally, including QED.
- CompScience — Kinetic Eye's ground-breaking technology allows for detection of risk within hours rather than days. Protecting your bottom-line and more importantly, your employees.
Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Series A
- Geography: Hong Kong
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
The International Medical is an investment firm
Show more...Investment focus
- Industry: Medical, Hospitality, Biotechnology
- Stage:Seed
- Geography: Hong Kong
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BioMed Technology Holdings — BioMed develops a personalized intestinal treatment plan with probiotics, a series of probiotic products for adults and children, to solve problems such as moisture sensitivity, detoxification, weight loss, emotional stress, etc., recommend the best adult and children probiotics for you, buy now!
Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Biopharma
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Hong Kong
Investor stats
- Total investments: 39
- Round size: Seed $1.3M–$12M; Series A $17M–$61M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
- cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
- Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
Longevity Vision Fund is a $100M investment fund dedicated to making longevity affordable and accessible to all. The fund accelerates longevity breakthroughs by investing in companies that develop technologies, products, and services that extend healthy human lifespans and overcome the negative effects of agingLongevity Vision Fund provides Seedto Series C funding to biotech and life extension-focused companies that have demonstrated affordable longevity potential and vision of milestones driving up the value of the company and market validation.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, Hong Kong, Isle of Man
Investor stats
- Total investments: 21
- Round size: Series B $37M–$230M; Series C $65M–$300M
- Lead/follow: 5% lead, 95% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Biolinq — Introducing a revolutionary platform for metabolic health.
- Senda Biosciences — We work at the frontier of programmable medicines. We power our bioplatform and product candidates by harnessing evolution and AI. We operate with purpose and urgency on behalf of people everywhere. We aim to generate life-changing impact for the world.
- Tessera Therapeutics — Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine,building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Proxima Ventures is focused on the management of investment portfolios for its customers. It offers them with financial products and consulting services. Proxima Ventures was acquired by Soluto in October 2013. Proxima Ventures was founded by Chaim Venezia and Uri Ra'anan and is based in Tel Aviv, Israel.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: China, United States, Israel
Investor stats
- Total investments: 20
- Round size: Seed $750k–$4.5M; Series A $213k–$10M; Series B $10M–$150M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
- Yidianling — Yidianling is a psychological counselling platform that provides free mental health services such as free questions and answers, psychological tests, expert services, and training lectures.
- Immune-Onc Therapeutics — Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Ping An Insurance Company is a holding company deals with insurance, banking, and financial service.
Show more...Investment focus
- Industry: Health Care, FinTech, Finance
- Stage:Series A, Series E
- Geography: China, United States, Japan
Investor stats
- Total investments: 28
- Round size: Series A $1.4M–$300M; Series E $7.1M–$200M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Lixiangjia — The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high networth families. Professional overseas asset reconfiguration plan.
- Biren Technology — Biren Technology is a high-tech startup that has the niche in softwares, hardwares, and chip system.The niche software department is led by the industry's top talents, composed of field technical experts and software elite engineers. The niche hardware department is committed to building a wide range of computing solutions based on generalcomputing, combining versatility and specificity.As a frontier research department of the niches, the Institute aims to study the key technologies of new intelligent computing systems, focusing on new architectures and advanced compilation technologies.
- Hangzhou Yingde Gas — Hangzhou Yingde Gas is a company that specializes in the manufacturing and sales of industrial automatic control system devices and electrical signal equipment.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!With more than 30 portfolio companies across AI, pet health, ageing medicine and more, LongeVC provides venture capital for the biotech and longevity sectors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 15
- Round size: Seed $1.5M–$12M; Series A $17M–$94M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Catena Biosciences — Catena Biosciences uses a novel protein conjugation method to bring breakthroughs in biological therapeutics, autoimmune disorders and vaccine development
- Valink Therapeutics — Valink is developing a series of novel therapeutics that are more effective at attacking tumours, while sparing healthy tissue.
- PreComb — PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.
DNA Capital is an investment partnership specializing in multi-stage investments in the healthcare sector.
Show more...Investment focus
- Industry: Health Care, Medical, Hospital
- Stage:Seed, Series A, Series B
- Geography: United States, Brazil, China
Investor stats
- Total investments: 36
- Round size: Seed $250k–$8M; Series A $2M–$30M; Series B $3.6M–$30M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Piwi — Hi there, we are Piwi®. Like a broker, only easier. We didn’t create the company because we were in love with the market. It was exactly the opposite. With an easy to use and intuitive digital benefit managing platform we replaced the old school brokerage changing the way in which companies research, buy and manage their health plans and benefits.That’s evolution coming around!
- Reema Health — Transforming the way people navigate the gaps between health care and social care. Reema combines a 24/7 AI-based confidant with in-person community guides to help people meet their social needs.
- Sanar — 26K Followers, 709 Following, 489 Posts - See Instagram photos and videos from Sanar (@sanar)
We take a diversified approach, investing in the early stage, across multiple sectors with our deep domain expertise.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: United States, Taiwan, China
Investor stats
- Total investments: 150
- Round size: Seed $1.4M–$5M; Series A $2M–$15M; Series B $6M–$41M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $174M in 2016
Portfolio highlights
- DivX — Download free DivX Software to play, convert and cast video including DivX, AVI, MKV and HEVC files up to 4K. Play AVI and convert to MP4!
- AIM — AIM focuses on affordable and easy access to early preventive detection, precision diagnosis and automated prognosis monitoring of prevailing chronic diseases at vast installations of points-of-care.
- Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Angel
- Geography: China, United States, Germany
Investor stats
- Total investments: 133
- Round size: Angel $425k–$15M; Series A $1.4M–$63M; Series B $3.5M–$90M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $430M in 2018
Portfolio highlights
- Baijun Biotech — Baijun Biotechnology is a major player in the field of biopharmaceutical R&D services due to its one-stop biotechnology R&D service platform, strong R&D skills, and extensive industry experience.
- GenFleet Therapeutics — GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize thebody's own immune system.
- MicuRx Pharmaceuticals — MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available inChina. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.
Capital Union Investments is a leader in private investment for early stage, growth, mezzanine, and pre-IPO capital. Headquartered in Hong Kong; and with offices in China and the US, the Firm's investment philosophy has been to create value by identifying leaders and innovators, whose businesses that can be developed in Asia. Our approach ofproviding unique investment insights, local knowledge and value-added operating capabilities, differentiates us from many traditional private investment funds.
Show more...Investment focus
- Industry: SaaS, Genetics, Software
- Stage:Seed, Series A
- Geography: Hong Kong, United States
Investor stats
- Total investments: 3
- Round size: Seed $2M–$10M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bringhub — Bringhub is a contextual marketing platform that enables digital media and marketers to drive product discovery and sales. We have developed the most comprehensive contextual analysis and optimization engine on the market. We call it Sweeten.
- Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
- Dash Living — Dash Living offers rental services and solutions for urban professionals. Dash offers panoramic all-inclusive rental options across over 1,000 units that they manage. Their mission is to create a global accommodation community through sharing economies and tech, empowering today's hyper-mobile, tech-savvy millennials to live in the expensivecities in the world.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series A, Series C
- Geography: China, United States, Singapore
Investor stats
- Total investments: 331
- Round size: Series A $2.9M–$142M; Series B $14M–$230M; Series C $15M–$220M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $11B in 2018
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
AngelsDeck Global Ventures. Joint investments and exclusive community.AngelsDeck was created:01 For comfortable and mutually beneficial communication among its members, who share venture capital and self-development values. 02 For priority access to venture capital deals with a recommendation from trusted syndicators.03 By and forinvestors who have an impeccable business reputation and capital transparency.Our Values:* Expertise * We are proud of our members' combined expertise. We create and maintain an environment where all members can conveniently and comfortably share their valuable knowledge.* Exclusivity * In the venture capital market, there is a lot of competition among investors for promising projects. We showcase exclusive deals that are not on the surface.* Syndication * We have created a marketplace where experienced syndicate investors can compete for members' attention by the quality of their deals. Everyone can try the role of a syndicator.* Communication * "As a fish needs water, an investor needs a network," and we have created an exclusive club with a unique atmosphere of online and offline communication between members of equal enthusiasm, aspiration, and motivation.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Education
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, Russian Federation, Brazil
Investor stats
- Total investments: 44
- Round size: Seed $260k–$6M; Angel $80k–$895k; Pre-Seed $200k–$621k
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- CLOSO — CLOSO eliminates e-commerce return costs for retailers, provides sellers with inventory, and helps grow their business.
- GPU AUDIO — GPU Audio's Early Access program is a free community for users and developers to be part of the benchmarking process for new audio plugins and technology. GPU Audio is the world's only full-stack solution for powering the future of audio using the power of modern GPUs like NVIDIA and AMD.
- Yalla!Market — YallaMarket / Fast grocery delivery from 15 minutes
A.Partners invests globally in early-stage startups. We believe that successful business models arise in different regions often simultaneously and we can leverage this phenomenon. Nonetheless, we are especially keen on emerging markets, such as LatAm, MENA, and SEA.
Show more...Investment focus
- Industry: Education, EdTech, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Russian Federation, Peru
Investor stats
- Total investments: 18
- Round size: Seed $1.1M–$6.4M; Pre-Seed $700k–$700k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- InTone — We Reduce Accent. In a single click.
- Refocus — Making people in SEA master new skills from scratch and land their first job in IT
- Crabi — Full stack, digital car insurance
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 227
- Round size: Seed $120k–$5M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Coent Venture Partners provides seed and venture-stage funding to brilliant entrepreneurs and companies across all sectors in Asia. The company backed these entrepreneurs and companies with unparalleled support in funding, management, overseas business development, and exposure to their network.
Show more...Investment focus
- Industry: Apps, SaaS, Travel
- Stage:Seed, Series A
- Geography: Taiwan, China, Hong Kong
Investor stats
- Total investments: 4
- Round size: Seed $275k–$800k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- QLL — QLL (Quick Language Learning) Pte. Ltd. is a company specialized in developing language learning apps, they are based in Taiwan and registered in Singapore. 2007, they launched a break-through Chinese learning gadget, “Pocket Chinese Tutor”, it is an Mp4 player with Chinese speech assessment function, it can help learner correct their accent ofspeaking Chinese.
- Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
- HelloWings — "See" the cheapest fare, year-round and fees included. Customized combination tickets. HelloWings ensures you'll arrive to destination on budget & in style.
Health Care VC funding in Hong Kong at a glance
Stats across 110 deals from 215 investors.
Access all 215 VC funds in Hong Kong Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Hong Kong investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 215 VC funds investing in Hong Kong Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!